the effectiveness of Rocaltrol on treatment of albuminuria in pateint with diabetic nephropathy.
Phase 4
- Conditions
- diabetic nephropathy.Non-insulin-dependent diabetes mellitus with renal complications
- Registration Number
- IRCT2015110624903N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 132
Inclusion Criteria
aged between 40-70 years; diabetes mellitus type 2 that at least 3 months past diagnosis; Albuminuria is (urinary albumin >30 mg/24 hours); Signing Informed consent form; ca <9.5 and p <5.5; Not having an active urine analysis regarding Hematuria, pyuria and urine cast or crystal.
Exclusion criteria: K > 5.5 mg per deciliter or creatinine rising more than 30% after administration of Losartan; administration of vitamin D agents; acute infectious disease; acute heart failure; cancer; pregnancy; Urinary protein more than 8 gr/24 hours; vitamin D deficiency.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1C. Timepoint: 3 month later. Method of measurement: labratory study.;Albumin to createnin ratio. Timepoint: 3 month later. Method of measurement: labratory study.
- Secondary Outcome Measures
Name Time Method Ca. Timepoint: 3 month later. Method of measurement: Labratory Study.;P. Timepoint: 3 month later. Method of measurement: Labratory Study.